Sugi Predict

Sugi Predict / Compounds / Demannose

Demannose

Demannose

SCHEMBL6055085

O=C[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.52
▸ PDE4A P27815 1/20 0.44
▸ AKR1B1 P15121 1/20 0.42
▸ USP2 O75604 1/20 0.41
▸ SLCO1B1 Q9Y6L6 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.39
▸ MPI P34949 1/20 0.34
▸ CYP2C19 P33261 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ TOP1 P11387 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Demannose SCHEMBL3904983 1.00 LMNA (0.55) LMNAL3MBTL1TDP1PDE4AAKR1B1
Demannose SCHEMBL6750831 1.00 LMNA (0.55) LMNAL3MBTL1TDP1PDE4AAKR1B1
Galactose SCHEMBL14856251 1.00 LMNA (0.55) LMNAL3MBTL1TDP1PDE4AAKR1B1
Demannose SCHEMBL8528284 1.00 LMNA (0.55) LMNAL3MBTL1TDP1PDE4AAKR1B1
Galactose SCHEMBL1548813 1.00 LMNA (0.55) LMNAL3MBTL1TDP1PDE4AAKR1B1
Demannose SCHEMBL22712624 1.00 LMNA (0.55) LMNAL3MBTL1TDP1PDE4AAKR1B1
Demannose SCHEMBL2799182 1.00 LMNA (0.55) LMNAL3MBTL1TDP1PDE4AAKR1B1
Demannose SCHEMBL461962 1.00 LMNA (0.55) LMNAL3MBTL1TDP1PDE4AAKR1B1
Demannose SCHEMBL20817166 1.00 LMNA (0.55) LMNAL3MBTL1TDP1PDE4AAKR1B1
Demannose SCHEMBL1858493 1.00 LMNA (0.55) LMNAL3MBTL1TDP1PDE4AAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4582807-A AMINO ACIDS, SUGARS, PHOSPHOLIPIDS, MUSCLE METABOLISM COMPOUNDS, VITAMINS, INORGANIC SALTS AND TRACE MINERALS VEERARAGHAVAN NATTERI 1986-04-15 — — US claimed
US-20190106718-A1 LIGNOCELLULOSIC CONVERSION PROCESS COMPRISING SULFUR DIOXIDE AND/OR SULFUROUS ACID PRETREATMENT IOGEN CORPORATION (CA) 2019-04-11 — — US disclosed
CN-108042799-A cationic oil-in-water emulsion 诺华股份有限公司 2018-05-18 — — CN disclosed
WO-2016145528-A1 LIGNOCELLULOSIC CONVERSION PROCESS COMPRISING SULFUR DIOXIDE AND/OR SULFUROUS ACID PRETREATMENT IOGEN CORPORATION (CA) 2016-09-22 — — WO disclosed
CN-103327963-A Cationic oil-in-water emulsions NOVARTIS AG 2013-09-25 — — CN disclosed
EP-2576023-A1 SEPARATION PROCESS Dupont Nutrition Biosciences ApS (DK) 2013-04-10 — — EP disclosed
US-7147859-B2 Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers LABORATORIOS BIOSINTETICA LTDA. (BR) 2006-12-12 — — US disclosed
US-20060039932-A1 Application of phytosteroids (and isomers thereof), folic acid, cyanocobalamine and pyridoxine in dietetic (alimentary) fibers LABORATORIOS BIOSINTETICA LTDA. (BR) 2006-02-23 — — US disclosed
CN-1170925-C Fermentation production process of alkaline mycose lyase and microbe for producing the lyase 中国科学院微生物研究所 2004-10-13 — — CN disclosed
US-20030133965-A1 Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers LABORATORIOS BIOSINTETICA LTDA. (BR) 2003-07-17 — — US disclosed
US-20020018811-A1 Application of phytosteroids(and isomers thereof), folic acid, cyanocobalamine and pyridoxine in dietetic (alimentary) fibers LABORATORIOS BIOSINTETICA LTDA. (BR) 2002-02-14 — — US disclosed
CN-1335393-A Fermentation production process of alkaline mycose lyase and microbe for producing the lyase INST OF MICROBIOLOGY ACADEMIA (CN) 2002-02-13 — — CN disclosed
EP-1019547-A1 METHOD FOR RECOVERING AN ORGANIC COMPOUND FROM SOLUTIONS XYROFIN OY (FI) 2000-07-19 — — EP disclosed
US-6027747-A A SOLID DISPERSION OF ENHANCED BIOAVAILABITY BY DISSOLVING FENOFIBRATE IN A VOLATILE SOLVENT CONTAINING A HYDROPHILIC POLYMER; DRYING BY EVAPORATION TO FORM A COPRECIPITATE; INCREASED WATER SOLUBILITY; SURFACTANTS TERRACOL DIDIER (FR) 2000-02-22 — — US disclosed
EP-0820527-A1 METHOD FOR RECOVERY OF XYLOSE FROM SOLUTIONS XYROFIN OY (FI) 1998-01-28 — — EP disclosed
WO-1996027028-A1 METHOD FOR RECOVERY OF XYLOSE FROM SOLUTIONS XYROFIN OY (FI) 1996-09-06 — — WO disclosed
CN-1041090-A The Hydrolyze method of partially extracted roasted and ground coffee GEN FOODS CORP (US) 1990-04-11 — — CN disclosed
US-4590161-A AEROBIC CULTIVATION OF BREUIBACTERIUM DEGUSSA AKTIENGESELLSCHAFT (DE) 1986-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020018811-A1 Application of phytosteroids(and isomers thereof), folic acid, cyanocobalamine and pyridoxine in dietetic (alimentary) fibers PLPBP, FOLR2, FOLR1 LMNA 760/4885L3MBTL1 1111/4885TDP1 3161/4885
US-20060039932-A1 Application of phytosteroids (and isomers thereof), folic acid, cyanocobalamine and pyridoxine in dietetic (alimentary) fibers PLPBP, FOLR2, FOLR1 LMNA 778/4885L3MBTL1 1086/4885TDP1 3304/4885
US-20030133965-A1 Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers PLPBP, FOLR2, FOLR1 LMNA 754/4885L3MBTL1 764/4885TDP1 3052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.